Guideline Requests

One of the INTERACT Coalition’s primary goals is to increase appropriate access to genetic testing for hereditary cancer. We regularly submit formal, evidence-based requests to the National Comprehensive Cancer Network (NCCN) expert panels in advance of their guideline update meetings. These requests are reviewed and decided upon by the panel and summarized in a public transparency document. The table below summarizes the history of our requests and the NCCN’s decisions.

NCCN Panel

Date

Outcomes

Genetic/Familial High-Risk Assessment: Colorectal

11/05/2020

For more information, see NCCN Transparency Document available at Transparency Process (nccn.org)

Genetic/Familial High-Risk Assessment: Breast, Ovarian, Prostate

03/17/2021

For more information, see NCCN Transparency Document available at Transparency Process (nccn.org)

Uterine Neoplasms

05/21/2021

For more information, see NCCN Transparency Document available at Transparency Process (nccn.org)

Gastric Cancer

08/17/2021

For more information, see NCCN Transparency Document available at Transparency Process (nccn.org)

Genetic/Familial High-Risk Assessment: Colorectal

11/03/2021

For more information, see NCCN Transparency Document available at Transparency Process (nccn.org)

Genetic/Familial High-Risk Assessment: Breast, Ovarian, Prostate

02/22/2022

For more information, see NCCN Transparency Document available at Transparency Process (nccn.org)

Kidney Cancer

03/17/2022

For more information, see NCCN Transparency Document available at Transparency Process (nccn.org)

Prostate Cancer

04/05/2022

For more information, see NCCN Transparency Document available at Transparency Process (nccn.org)